scispace - formally typeset
Open AccessJournal ArticleDOI

Moody microbiome: Challenges and chances.

TLDR
Results from recent clinical trials support for the beneficial effects of probiotics on alleviating depressive symptoms and increasing well-beings and modifying the composition of gut microbiota via antibiotics can be a viable adjuvant treatment option for individuals with depressive symptoms.
About
This article is published in Journal of the Formosan Medical Association.The article was published on 2019-03-01 and is currently open access. It has received 27 citations till now. The article focuses on the topics: Microbiome & Gut–brain axis.

read more

Citations
More filters
Journal ArticleDOI

Stress and the gut microbiota-brain axis

TL;DR: The influence of stress on gut microbiota and gut microbiota on stress modulation is clear for different stressors, but although the preclinical evidence is so extensive, the clinical evidence is more limited.
Journal ArticleDOI

Probiotics and prebiotics: focus on psychiatric disorders - a systematic review.

TL;DR: Although recent findings in specific psychiatric disorders are encouraging, the use of prebiotics and probiotics in clinical practice stills lacks sufficiently robust evidence.
Journal ArticleDOI

Gut microbiome patterns depending on children's psychosocial stress: Reports versus biomarkers.

TL;DR: Even in this young healthy population, stress parameters were cross-sectionally associated with gut microbial composition but this relationship was instrument specific.
Journal ArticleDOI

The role of the gut-brain axis in depression: endocrine, neural, and immune pathways.

TL;DR: The bidirectional link between the gut and the brain is of great importance for the development of novel therapeutic strategies against depression, offering promising alternatives to limited efficacy antidepressants, while combination therapy also remains a potential treatment option.
References
More filters
Journal ArticleDOI

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

TL;DR: The emerging concept of a microbiota–gut–brain axis suggests that modulation of the gut microbiota may be a tractable strategy for developing novel therapeutics for complex CNS disorders.
Journal ArticleDOI

Animal models of neuropsychiatric disorders

TL;DR: The current state of animal models of mental illness, with a focus on schizophrenia, depression and bipolar disorder, is reviewed and it is argued for areas of focus that might increase the likelihood of creating more useful models, at least for some disorders.
Journal ArticleDOI

Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

TL;DR: The neurodegenerative hypothesis of depression explains decreased hippocampal volumes in depressed patients and changes of neurotrophic support by BDNF, erythropoietin, GDNF, FGF-2, NT3, NGF and growth hormone.
Journal ArticleDOI

Altered fecal microbiota composition in patients with major depressive disorder

TL;DR: Fecal samples from 46 patients with depression are analyzed to enable a better understanding of changes in the fecal microbiota composition in such patients, showing either a predominance of some potentially harmful bacterial groups or a reduction in beneficial bacterial genera.
Journal ArticleDOI

Estimating the true global burden of mental illness.

TL;DR: It is argued that the global burden of mental illness is underestimated and the reasons for under-estimation are examined to identify five main causes: overlap between psychiatric and neurological disorders; the grouping of suicide and self-harm as a separate category; conflation of all chronic pain syndromes with musculoskeletal disorders; exclusion of personality disorders from disease burden calculations; and inadequate consideration of the contribution of severe mental illness to mortality from associated causes.
Related Papers (5)